New Journey Health Technology Group Co.,LTD (SHE:002219)
China flag China · Delayed Price · Currency is CNY
1.890
0.00 (0.00%)
Oct 30, 2026, 3:04 PM CST

SHE:002219 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
68.3130.94114.7728.97156.12-371.43
Depreciation & Amortization
180.48187.18215.95238.04166.52163.29
Other Amortization
46.0839.3828.7629.6618.7614.75
Loss (Gain) From Sale of Assets
-0.23-0.230.070.19-00.7
Asset Writedown & Restructuring Costs
1.251.251.01329.46119.71
Loss (Gain) From Sale of Investments
3.343.41-2.57-11.85-47.84-25.69
Provision & Write-off of Bad Debts
60.9460.9431.7572.65-105.03
Other Operating Activities
-15.67131.2169.12181.26151.35299.76
Change in Accounts Receivable
-20.43-22.58-117.35-162.1-160.17-70.23
Change in Inventory
51.0951.0925.21-47.0119.52-7.27
Change in Accounts Payable
-168.23-168.66-43.0122.19-46.2871.76
Operating Cash Flow
186.81293.79438.51320.93268.04277.29
Operating Cash Flow Growth
-49.22%-33.00%36.64%19.73%-3.34%-2.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-201.15-257-307.44-209.68-221.58-198.73
Sale of Property, Plant & Equipment
0.260.211.840.390.281.35
Cash Acquisitions
-26.97-161.93-172.92-139.54-18-1
Divestitures
-02.150.767-
Investment in Securities
---13.95-5.181-1
Other Investing Activities
-50--0.26-21.010.29
Investing Cash Flow
-277.85-418.73-490.31-353.05-192.31-199.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-53.655.6416.5266.6554.42
Long-Term Debt Issued
-1,4471,6081,358374.63374.86
Total Debt Issued
1,4701,5011,6141,374441.28429.28
Short-Term Debt Repaid
--119.49-48.44-91.25--15.37
Long-Term Debt Repaid
--1,345-1,603-1,309-1,695-383.95
Lease Payments
-217.23-217.23-169.71-107.81--
Total Debt Repaid
-1,611-1,465-1,652-1,400-1,695-399.33
Net Debt Issued (Repaid)
-141.7835.91-38.35-25.78-1,25429.95
Issuance of Common Stock
90.36112.7112.7284.390.591,794
Repurchase of Common Stock
---55.32-19.51--
Common Dividends Paid
-91.41-100.71-118.24-106.17-275.82-54.18
Other Financing Activities
148.61-3-10.53-86.53--0.08
Financing Cash Flow
5.7944.9-109.7346.4-1,5291,770

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0-0000-0
Net Cash Flow
-85.25-80.04-161.5314.28-1,4531,848

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-14.3436.78131.06111.2546.4778.56
Free Cash Flow Growth
--71.94%17.81%139.42%-40.86%16.87%
Free Cash Flow Margin
-0.49%1.21%3.45%2.84%1.47%2.60%
Free Cash Flow Per Share
-0.000.010.040.030.010.04
Levered Free Cash Flow
-213.98-73.42167.81-499.96-716.26239.26
Unlevered Free Cash Flow
-195.063.72252.2-419.66-627.12383.03
Free Cash Flow After Leases
-231.56-180.45-38.653.4446.4778.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
107.8295.7107.19120.240.1118.06
Change in Working Capital
-157.69-160.28-120.35-221-206.33-28.82